What is Thesis?
Thesis Care operates at the intersection of artificial intelligence and clinical practice, developing an AI-powered clinical support platform. This technology is engineered to bolster the capacity of healthcare organizations by intelligently automating tasks and providing oversight from experienced clinicians. The platform facilitates scalable management of care operations, seamless integration with existing healthcare workflows, and ultimately aims to enhance patient engagement and improve health outcomes. The company's focus on combining automation with human expertise positions it as a key innovator in addressing the growing demands on healthcare systems.
How much funding has Thesis raised?
Thesis has raised a total of $60M across 2 funding rounds:
Seed
$15M
Series A
$45M
Seed (2024): $15M, investors not publicly disclosed
Series A (2026): $45M led by Charles River Ventures, Oak HC/FT, and Black Opal Ventures
Key Investors in Thesis
Charles River Ventures
Charles River Ventures (CRV) is a venture capital firm specializing in early-stage technology startups. With a history dating back to 1970, CRV has a proven track record of supporting companies from inception through IPO, acting as a committed, long-term partner to founders.
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund established in 2014, focusing on investments in Healthcare Information & Services and Financial Services Technology. The firm provides strategic counsel and access to an extensive network to drive transformation in these sectors.
Black Opal Ventures
Black Opal Ventures is an investment firm dedicated to supporting founders at the nexus of healthcare and technology. They focus on innovative solutions addressing critical challenges in healthcare and security, aiming to foster transformational companies through collaboration and diverse perspectives.
What's next for Thesis?
The recent major enterprise-level funding and strategic investment signal Thesis's readiness for accelerated expansion and market penetration. With this capital injection, the company is poised to further develop its AI capabilities, scale its operations, and broaden its reach within the healthcare technology landscape. Future strategic initiatives will likely focus on enhancing platform features, forging new partnerships, and solidifying its position as a leader in AI-driven clinical support, aiming to redefine efficiency and patient care standards across the industry.
See full Thesis company page
